S. L. Beal, Ways to fit a PK model with some data below the quantification limit, Journal of Pharmacokinetics and Pharmacodynamics, vol.28, issue.5, pp.481-504, 2001.
DOI : 10.1023/A:1012299115260

S. L. Beal and L. B. Sheiner, NONMEM User's Guide; NONMEM project group, 1998.

M. Capparelli, Mirochnick, and a. f. t. P. I. P. s. Team, Presented at the 15th Conference on Retroviruses and Opportunistic Infections, pp.3-6, 2008.

M. R. Blum, G. E. Chittick, J. A. Begley, and J. Zong, Steady-State Pharmacokinetics of Emtricitabine and Tenofovir Disoproxil Fumarate Administered Alone and in Combination in Healthy Volunteers, The Journal of Clinical Pharmacology, vol.39, issue.6, pp.751-760, 2007.
DOI : 10.1177/0091270007300951

R. Ihaka and R. Gentleman, R: a language for data analysis and graphics, J Comput Graph Stat, vol.5, p.299, 1996.

L. M. Fowler, M. Mofenson, F. Mirochnick, S. H. Mmiro, and . Eshleman, Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission, AIDS, vol.14, pp.111-116, 2000.

B. Krauer, F. Krauer, and F. E. Hytten, Drug disposition and pharmacokinetics in the maternal-placental-fetal unit, Pharmacology & Therapeutics, vol.10, issue.2, pp.301-329, 1980.
DOI : 10.1016/0163-7258(80)90085-6

. Jullien, Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, vol.865, pp.81-90, 2008.

R. Loebstein, A. Lalkin, and G. Koren, Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance, Clinical Pharmacokinetics, vol.33, issue.5, pp.328-371, 1997.
DOI : 10.2165/00003088-199733050-00002

M. Mirochnick, Antiretroviral Pharmacology in Pregnant Women and Their Newborns, Annals of the New York Academy of Sciences, vol.42, issue.1, pp.287-97, 2000.
DOI : 10.1111/j.1749-6632.2000.tb05498.x

E. Parry, R. Shields, and A. C. Turnbull, TRANSIT TIME IN THE SMALL INTESTINE IN PREGNANCY, BJOG: An International Journal of Obstetrics and Gynaecology, vol.77, issue.10, pp.900-901, 1970.
DOI : 10.1111/j.1471-0528.1970.tb03423.x

S. Ramanathan, G. Shen, A. Cheng, and B. P. Kearney, Pharmacokinetics of Emtricitabine, Tenofovir, and GS-9137 Following Coadministration of Emtricitabine/Tenofovir Disoproxil Fumarate and Ritonavir-Boosted GS-9137, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.PAP, pp.274-283, 2007.
DOI : 10.1097/QAI.0b013e318050d88c

S. Rodriguez, A. Blanchard, and . Fridland, Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1- infected women and newborn infants, J Infect Dis, vol.180, pp.1844-50, 1999.

P. M. Emmanuel and . Flynn, Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children, Antimicrob Agents Chemother, vol.48, pp.183-91, 2004.

J. Zong, G. E. Chittick, L. H. Wang, J. Hui, J. A. Begley et al., Pharmacokinetic Evaluation of Emtricitabine in Combination With Other Nucleoside Antivirals in Healthy Volunteers, The Journal of Clinical Pharmacology, vol.191, issue.suppl 2A, pp.877-89, 2007.
DOI : 10.1177/0091270007300808